Laquinimod, a new oral drug for multiple sclerosis

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2059-2060
Number of pages2
JournalThe Lancet
Volume371
Issue number9630
DOIs
StatePublished - 2008

Fingerprint

Relapsing-Remitting Multiple Sclerosis
Quinolones
Multiple Sclerosis
Oral Administration
Pharmaceutical Preparations
laquinimod

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Laquinimod, a new oral drug for multiple sclerosis. / Keegan, B Mark; Weinshenker, Brian G.

In: The Lancet, Vol. 371, No. 9630, 2008, p. 2059-2060.

Research output: Contribution to journalArticle

@article{aa64db9792d34431b8156e05d3168ac5,
title = "Laquinimod, a new oral drug for multiple sclerosis",
author = "Keegan, {B Mark} and Weinshenker, {Brian G}",
year = "2008",
doi = "10.1016/S0140-6736(08)60894-6",
language = "English (US)",
volume = "371",
pages = "2059--2060",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9630",

}

TY - JOUR

T1 - Laquinimod, a new oral drug for multiple sclerosis

AU - Keegan, B Mark

AU - Weinshenker, Brian G

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=45249089662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45249089662&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(08)60894-6

DO - 10.1016/S0140-6736(08)60894-6

M3 - Article

C2 - 18572062

AN - SCOPUS:45249089662

VL - 371

SP - 2059

EP - 2060

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9630

ER -